We recently reiterated our ‘Neutral’ recommendation on Abaxis Inc. (ABAX) with a target price of $28.00. Abaxis reported EPS of 13 cents in the third quarter of fiscal 2012, missing the year-ago ...
UNION CITY, Calif., June 28, 2012 /PRNewswire via COMTEX/ -- Abaxis, Inc. (nasdaqgs:ABAX), a company manufacturing point of care instrumentation and consumables for the medical, veterinary, and ...
Lab-accurate blood chemistry analysis in real time will now be available in Canada thanks to Abaxis, Inc. ( ABAX) which won Class III approval from Health Canada for its Piccolo Xpress and Piccolo ...
UNION CITY, Calif., Oct. 31, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the Company has signed ...
Abbott’s point of care business negotiated exclusive rights to distribute Abaxis’ Piccolo Xpress® portable blood chemistry analyzer and full range of one-time use reagent discs for human health ...
Dublin, Dec. 16, 2020 (GLOBE NEWSWIRE) -- The "Veterinary Chemistry Analyzers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results